Self‐Accelerated Nanoregulators for Positive Feedback Ferroptosis‐Immunotherapy
Small · 2025
DOI: 10.1002/smll.202408156 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Xu Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Faculty of Medicine, Tianjin University, Tianjin, 300072, P. R. China. Hauptthemen laut MEDLINE: Ferroptosis, Immunotherapy, Nanoparticles. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Activating specific immunity through intelligent delivery of chemotherapeutic drugs shows great potential for effective tumor therapy. However, conventional tumor microenvironment‐responsive nanomedicines are often difficult to achieve both specificity and sensitivity, leading to severe adverse effects or limited drug release efficiency. Furthermore, the immunosuppressive microenvironment of tumor will also seriously restrict the treatment efficacy. In this work, a cascade‐responsive multi‐polyprodrug nanoregulator is developed. Under the tumor microenvironment with high hydrogen peroxide level, the nanoregulators can simultaneously release chemotherapeutic drugs (doxorubicin), indoleamine 2,3‐dioxygenase 1 inhibitor (1‐methyl‐tryptophan) and cinnamaldehyde in a self‐accelerating manner. The combination of reactive oxygen species‐induced ferroptosis and doxorubicin‐induced apoptosis can synergistically enhance immunogenic cell death and activate the immune response. The released1‐methyl‐tryptophan can promote cytotoxic T lymphocyte activation and reduce immune escape by inhibiting the tryptophan conversion. Meanwhile, it also enhances ferroptosis by inhibiting reactive oxygen species scavenging and cystine/glutamate antiporter expression, achieving the positive feedback ferroptosis‐immunotherapy. This work provides a self‐accelerated drug delivery strategy and a potential cooperation mode for tumor synergistic immunotherapy based on ferroptosis‐apoptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Faculty of Medicine, Tianjin University, Tianjin, 300072, P. R. China.
- Department of Diagnostic Radiology, Department of Chemical and Biomolecular Engineering, Department of Biomedical Engineering, Department of Pharmacy and Pharmaceutical Sciences, National University of Singapore, Singap…
- Department of Chemical and Biomolecular Engineering, College of Design and Engineering, National University of Singapore, Singapore, 117575, Singapore.
- Department of Biomedical Engineering, College of Design and Engineering, National University of Singapore, Singapore, 117575, Singapore.
- Department of Pharmacy and Pharmaceutical Sciences, Faculty of Science, National University of Singapore, Singapore, 117544, Singapore.
- Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117599, Singapore.
ORCID-Profile: Xiaoyuan Chen
Förderung
- National Natural Science Foundation of China
- National Key R&D Program of China
- China Postdoctoral Science Foundation
- Tianjin Joint Support Program
- Postdoctoral Fellowship Program of CPSF
- National Medical Research Council
- National Research Foundation
- National University of Singapore
Zitieren
APA
Zhang, X., Zhang, X., Fan, Q., Li, J., Jia, S., Chen, X., & Wang, S. (2025). Self‐Accelerated Nanoregulators for Positive Feedback Ferroptosis‐Immunotherapy. Small. https://doi.org/10.1002/smll.202408156
Vancouver
Zhang X, Zhang X, Fan Q, Li J, Jia S, Chen X, et al. Self‐Accelerated Nanoregulators for Positive Feedback Ferroptosis‐Immunotherapy. Small. 2025. doi:10.1002/smll.202408156
BibTeX
@article{Zhang2025,
author = {Zhang, Xu and Zhang, Xinlu and Fan, Qin and Li, Jiansen and Jia, Shitian and Chen, Xiaoyuan and Wang, Sheng},
title = {Self‐Accelerated Nanoregulators for Positive Feedback Ferroptosis‐Immunotherapy},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202408156}
}
EUVIMED